Predictive Oncology Debt 2024

Predictive Oncology Aktienanalyse

What does Predictive Oncology do?

Predictive Oncology Inc is an emerging company in the field of cancer research and treatment. It was founded in 2002 under the name Precision Therapeutics and has since focused on developing new diagnostic and therapeutic procedures for cancer. The business model of Predictive Oncology is based on collaboration with pharmaceutical companies and research institutions to develop new technologies and products for cancer therapy. The focus is on personalized medicine, which enables treatment options tailored to individual patient needs. The company is divided into several divisions, each covering different areas of cancer research. These include predictive medicine, pharmacy, and diagnostics. Predictive Oncology has developed several products that can be used in predictive medicine. This includes the OncoTect iOCT System, which allows prediction of the effectiveness of chemotherapy for a specific type of cancer. Based on genetic analysis, the system can determine before treatment whether the drug used for chemotherapy is actually effective or if another drug may be more suitable. Another important product of Predictive Oncology is the Skyline Ventures Test Kit, which is used in pharmacy. The kit allows pharmaceutical companies to test the potential effect of a new drug on specific cancer cells before testing it on patients in clinical trials. By pre-testing the effectiveness, unnecessary studies can be avoided and the development of new drugs can be accelerated. In the field of diagnostics, Predictive Oncology has developed the Cchek system, which enables early detection of certain types of cancer through RNA analysis. The system can provide indications of the development of a tumor at an early stage, enabling early treatment. One of the recent developments of Predictive Oncology is the acquisition of Soluble Therapeutics Inc, which specializes in protein analysis. Through the acquisition, Predictive Oncology hopes to further increase its capacities in personalized cancer treatment. Overall, Predictive Oncology is one of the leading companies in the field of cancer research. Through a consistent focus on personalized medicine and close collaboration with research institutions and pharmaceutical companies, the company has already produced some promising developments. In the future, it is expected that Predictive Oncology will bring further innovative products and technologies to the market to treat cancer patients more effectively. Predictive Oncology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Predictive Oncology's Debt Structure

Predictive Oncology's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Predictive Oncology's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Predictive Oncology’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Predictive Oncology’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Predictive Oncology stock

What is the debt of Predictive Oncology this year?

Predictive Oncology has a debt level of -8.58 USD this year.

What was the debt of Predictive Oncology compared to the previous year?

The debt of Predictive Oncology has increased by -61.13% compared to the previous year dropped.

What are the consequences of high debt for investors in Predictive Oncology?

High debt can pose a risk for investors of Predictive Oncology, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Predictive Oncology?

Low debt means that Predictive Oncology has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Predictive Oncology affect the company?

An increase in debt of Predictive Oncology can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Predictive Oncology affect the company?

A reduction in debt of Predictive Oncology can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Predictive Oncology?

Some factors that can influence the debt of Predictive Oncology include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Predictive Oncology so important for investors?

The debts of Predictive Oncology are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Predictive Oncology take to change the debt?

To change the debt, Predictive Oncology can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Predictive Oncology pay?

Over the past 12 months, Predictive Oncology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Predictive Oncology is expected to pay a dividend of 0 USD.

What is the dividend yield of Predictive Oncology?

The current dividend yield of Predictive Oncology is .

When does Predictive Oncology pay dividends?

Predictive Oncology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Predictive Oncology?

Predictive Oncology paid dividends every year for the past 0 years.

What is the dividend of Predictive Oncology?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Predictive Oncology located?

Predictive Oncology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Predictive Oncology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Predictive Oncology from 9/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Predictive Oncology pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Predictive Oncology in the year 2023?

In the year 2023, Predictive Oncology distributed 0 USD as dividends.

In which currency does Predictive Oncology pay out the dividend?

The dividends of Predictive Oncology are distributed in USD.